Ignite Creation Date:
2024-05-06 @ 10:59 AM
Last Modification Date:
2024-10-26 @ 12:38 PM
Study NCT ID:
NCT03403712
Status:
COMPLETED
Last Update Posted:
2020-06-01
First Post:
2018-01-04
Brief Title:
A Study to Assess the Safety and the Efficacy of IV FosnetupitantPalonosetron 260 mg025 mg Combination Compared to Oral NetupitantPalonosetron 300 mg05 mg Combination for the Prevention of CINV in AC Chemotherapy in Women With Breast Cancer
Sponsor:
Helsinn Healthcare SA
Organization:
Helsinn Healthcare SA
Organization Data
Organization:
Helsinn Healthcare SA
Class:
INDUSTRY
Study ID:
NEPA-17-05
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Helsinn Healthcare SA
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| The Physicians Services Incorporated Foundation | OTHER |
| George Clinical Pty Ltd | INDUSTRY |